Virtual trials or siteless trials are defined as clinical trials/ clinical trial studies done partly or on the whole virtually. In this methodology, clinical research companies rely on mobile devices or wearable sensors such as a phone, watch, or even glasses can be used to collect medical data in the clinical research study.
On the other hand, patients are treated via telemedicine and medical devices during clinical testing. Healthcare providers can evaluate, diagnose, and treat through telemedicine in turn leading to faster treatment and better retention.
Studies show 80% of traditional clinical trials fail to meet targets in enrolling and retaining patients due to constant delays in patient traveling to the site, higher processing timelines indicating the importance of virtual clinical trials. Medical devices such as wearables or medical kits are given with instructions for the patient to follow. Devices also give alerts to adhere to medical prescriptions.
The technological transformation of patient recruitment can be seen in the online recruitment campaigns and online screening practices of the interested volunteers with online questionaries for a particular study. They provide Informed consent/e-consent through the web and are then monitored through devices or nurses visit them in case of any emergencies.
Procedures and tests to be done are delivered as kits with instructions or samples are collected by medical staff for lab testing. Patients report outcomes in real-time using e-diaries and the data is accessible by the HCP’s and other medical staff in case of any risks occurring due to medication.
In the case of virtual trials, the study personnel can visit the patient at a convenient time at any clinical trial phase. The general and adverse events can be reported remotely on a real-time basis.
Despite the challenges faced in virtual trials, several tier-1 clinical research companies have shifted towards digitalization and set their own virtual trials.
For example, Pfizer’s first randomized virtual trial REMOTE in 2011, failed as the patients were old and did not possess enough knowledge about technology. Sanofi conducted a virtual trial to test VERKKO a wireless glucose meter in 2015 and observed that the trial was successfully completed 30% early when compared to traditional trials. Novartis has also invested in virtual clinical trials in partnership with Science 37.
Site-less studies conducted remotely with technology aids concluded with efficiency in the management of trials based on time and cost. Early detection and identification of adverse events. The industry is in need of these technology-driven trials that can bring faster and safer drugs to the market.
Cloudbyz is focused on providing innovative solutions for life science customers. Cloudbyz CTMS solution offers to prescreen according to any specific study that can be accessed via mobile or any other device from any location across all four clinical trial phases.
The solution offers participants the possibility to review the consent as often as they require, giving them time to understand, clarify, and reflect on their choices.
Cloudbyz’s solution comes with an open API that can integrate with any handheld device collecting medical data. The solution comes with the capability to execute a Virtual trial approach starting from prescreening to the closeout stage leading to a shorter time to market for new drugs.
References
https://www.sciencedirect.com/science/article/pii/S014929181730200X
https://www.sciencedirect.com/science/article/pii/S2451865418300358
https://www.ncbi.nlm.nih.gov/pubmed/28213342
http://www.appliedclinicaltrialsonline.com/virtual-clinical-trials-future-patient-engagement
By Mythri Raghunandan